Summit Securities Group’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$231K Buy
+3,153
New +$231K 0.04% 151
2024
Q4
Sell
-197
Closed -$9K 556
2024
Q3
$9K Buy
+197
New +$9K ﹤0.01% 274